É. Hachulla

56.8k total citations · 5 hit papers
677 papers, 22.4k citations indexed

About

É. Hachulla is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, É. Hachulla has authored 677 papers receiving a total of 22.4k indexed citations (citations by other indexed papers that have themselves been cited), including 260 papers in Pathology and Forensic Medicine, 215 papers in Pulmonary and Respiratory Medicine and 199 papers in Rheumatology. Recurrent topics in É. Hachulla's work include Systemic Sclerosis and Related Diseases (234 papers), Systemic Lupus Erythematosus Research (108 papers) and Inflammatory Myopathies and Dermatomyositis (92 papers). É. Hachulla is often cited by papers focused on Systemic Sclerosis and Related Diseases (234 papers), Systemic Lupus Erythematosus Research (108 papers) and Inflammatory Myopathies and Dermatomyositis (92 papers). É. Hachulla collaborates with scholars based in France, Germany and Italy. É. Hachulla's co-authors include David Launay, Pierre‐Yves Hatron, Marc Humbert, B Devulder, M. Lambert, Jean Sibilia, Loı̈c Guillevin, Luc Mouthon, Yannick Allanore and Virginie Gressin and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

É. Hachulla

637 papers receiving 21.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary Arterial Hypertension in France

2006 1.4k citations Marc Humbert, Olivier Sitbon et al. profile →
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

2009 627 citations Isabelle Koné‐Paut, É. Hachulla et al. profile →
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

2005 520 citations É. Hachulla, Élisabeth Diot et al. profile →
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

2018 267 citations É. Hachulla, F. Maurier et al. profile →
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

2020 193 citations Yannick Allanore, É. Hachulla et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
É. Hachulla	8.3k	7.6k	6.1k	4.6k	4.3k	677	22.4k
Oliver Distler	7.9k 1.0×	12.6k 1.6×	3.7k 0.6×	3.7k 0.8×	5.3k 1.2×	610	25.5k
Loı̈c Guillevin	18.4k 2.2×	4.8k 0.6×	11.8k 1.9×	3.0k 0.6×	4.2k 1.0×	664	28.7k
Luc Mouthon	7.2k 0.9×	4.9k 0.6×	3.9k 0.7×	1.9k 0.4×	2.7k 0.6×	389	13.2k
Marco Matucci‐Cerinic	4.4k 0.5×	11.8k 1.5×	4.5k 0.7×	3.0k 0.6×	4.6k 1.1×	672	20.8k
Eric L. Matteson	10.3k 1.2×	3.2k 0.4×	12.4k 2.0×	2.9k 0.6×	4.0k 0.9×	465	25.5k
Christopher P. Denton	9.7k 1.2×	16.4k 2.1×	2.6k 0.4×	4.5k 1.0×	5.0k 1.1×	461	24.1k
Yannick Allanore	5.5k 0.7×	11.1k 1.4×	3.5k 0.6×	3.6k 0.8×	3.9k 0.9×	480	16.7k
Miguel Á. González‐Gay	8.4k 1.0×	2.3k 0.3×	13.5k 2.2×	2.9k 0.6×	6.3k 1.5×	799	25.0k
Peter A. Merkel	14.4k 1.7×	3.3k 0.4×	9.4k 1.6×	1.2k 0.3×	3.7k 0.8×	386	21.4k
Virginia Steen	6.0k 0.7×	11.8k 1.5×	3.7k 0.6×	3.7k 0.8×	3.2k 0.7×	200	16.9k

Countries citing papers authored by É. Hachulla

Since Specialization

Citations

This map shows the geographic impact of É. Hachulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Hachulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Hachulla more than expected).

Fields of papers citing papers by É. Hachulla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Hachulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Hachulla. The network helps show where É. Hachulla may publish in the future.

Co-authorship network of co-authors of É. Hachulla

This figure shows the co-authorship network connecting the top 25 collaborators of É. Hachulla. A scholar is included among the top collaborators of É. Hachulla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Hachulla. É. Hachulla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thoreau, Benjamin, Philippe Chafey, Guilhem Clary, et al.. (2025). Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD). Lara D. Veeken. 64(6). 4041–4050.

Nicolas, A., Sébastien Sanges, Louis Terriou, et al.. (2024). Non-allergic Hypersensitivity Reactions to Immunoglobulin Preparations in Antibody Deficiencies: What Role for Anti-IgA IgG and Complement Activation?. Clinical Reviews in Allergy & Immunology. 67(1-3). 47–57. 1 indexed citations

Soubrier, Martin & É. Hachulla. (2024). IgG4-Related Arterial Disease: An Unusual Case of Aortitis. The Journal of Rheumatology. 52(6). 618–619.

Bay, Pierre, Marc Pineton de Chambrun, Yves Allenbach, et al.. (2024). A 24/7 Pilot Remote Emergency Multidisciplinary Discussion for Rapidly Progressive Interstitial Lung Disease. CHEST Journal. 167(1). 183–187.

Debray, Marie‐Pierre, Antoine Beurnier, Pierre‐Antoine Juge, et al.. (2024). Characterisation of airway disease associated with Sjögren disease. RMD Open. 10(1). e003866–e003866. 1 indexed citations

Siegert, Elise, Dörte Huscher, Hélène Béhal, et al.. (2024). Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis. Lara D. Veeken. 64(3). 1270–1276.

Nguyen, Yann, Maxime Beydon, Jacques‐Eric Gottenberg, et al.. (2024). Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data. Arthritis & Rheumatology. 77(7). 876–883. 1 indexed citations

Chaigne, Benjamin, C. Agard, Yannick Allanore, et al.. (2023). Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort study. Journal of Internal Medicine. 294(4). 482–491. 1 indexed citations

Foray, Anne‐Perrine, Lorna Garnier, Christine Lombard, et al.. (2023). Assessment of type I interferon response in routine practice in France in 2022. RMD Open. 9(2). e003211–e003211. 8 indexed citations

10.

Sanges, Sébastien, Vincent Sobanski, Nicolas Lamblin, et al.. (2023). Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know – but is afraid to ask!. La Revue de Médecine Interne. 45(1). 26–40.

11.

Speca, Silvia, Méryem-Maud Farhat, Manel Jendoubi, et al.. (2023). Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis. Scientific Reports. 13(1). 15102–15102. 4 indexed citations

12.

Reumaux, Héloïse, et al.. (2022). Socio-professional impact and quality of life of cryopyrin-associated periodic syndromes in 54 patients in adulthood. Clinical and Experimental Rheumatology. 41(10). 2039–2043. 2 indexed citations

13.

Truchetet, Marie‐Elise, Élodie Drumez, Thomas Barnetche, et al.. (2022). Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort. RMD Open. 8(2). e002476–e002476. 2 indexed citations

14.

Rodrigues, François, Laurence Cuisset, Irina Giurgea, et al.. (2022). AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review. Lara D. Veeken. 61(12). 4827–4834. 10 indexed citations

15.

Nicolas, A., David Launay, S. Morell‐Dubois, et al.. (2021). Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients. La Revue de Médecine Interne. 42(9). 608–615. 3 indexed citations

16.

Bray, Fabrice, Thomas Guerrier, Silvia Speca, et al.. (2021). Passages in culture and stimulation conditions influence protein expression of primary fibroblasts. PROTEOMICS. 22(3). e2100116–e2100116. 1 indexed citations

17.

Talarico, Rosaria, Stefano Bombardieri, Gerd R Burmester, et al.. (2020). Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey. RMD Open. 6(2). e001344–e001344. 8 indexed citations

18.

Urbanski, G., Cécile Yelnik, Hélène Maillard, et al.. (2018). Antiphospholipid Syndrome With Isolated Isotype M Anticardiolipin and/or Anti-B2GPI Antibody Is Associated With Stroke. Stroke. 49(11). 2770–2772. 15 indexed citations

19.

Revuz, Sabine, Évelyne Decullier, Isabelle Ginon, et al.. (2017). Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability. PLoS ONE. 12(10). e0184227–e0184227. 20 indexed citations

20.

Gondran, G., A.L. Fauchais, M. Lambert, et al.. (2008). Primary Sjögren's syndrome in men. Scandinavian Journal of Rheumatology. 37(4). 300–305. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact